The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Circulating tumor cells: approaches to isolation and characterization
Open accessAbstract
Circulating tumor cells (CTCs) shed from primary and metastatic cancers are admixed with blood components and are thus rare, making their isolation and characterization a major technological challenge. CTCs hold the key to understanding the biology of metastasis and provide a biomarker to noninvasively measure the evolution of tumor genotypes during treatment and disease progression. Improvements in technologies to yield purer CTC populations amenable to better cellular and molecular characterization will enable a broad range of clinical applications, including early detection of disease and the discovery of biomarkers to predict treatment responses and disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486 · cited 1×
“In nonsmokers’ lung cancer, EGF receptor (EGFR) mutations are particularly relevant because they are predictive of a dramatic clinical response to EGFR kinase inhibitors (Lynch et al., 2004; Paez et al., 2004; Pao et al., 2004).”
Self-citationEGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,593
Pao, W., Miller, V., Zakowski, M., Doherty, J., Politi, K., Sarkaria, I., Singh, B., Heelan, R., Rusch, V., Fulton, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405220101 · Cited by 4,338
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Nagrath, S., Sequist, L. V., Maheswaran, S., Bell, D. W., Irimia, D., Ulkus, L., Smith, M. R., Kwak, E. L., Digumarthy, S., Muzikansky, A., et al. (2007) · Nature · doi:10.1038/nature06385 · Cited by 3,559
Self-citationTransitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Allard, W. J., Matera, J., Miller, M. C., Repollet, M., Connelly, M. C., Rao, C., Tibbe, A. G. J., Uhr, J. W., & Terstappen, L. W. M. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0378 · Cited by 2,542 · cited 2×
“…(see CTCs as prognostic markers), it suffers from relatively low sensitivity: only a fraction of patients with metastatic cancer scores positive for any CTCs, with a median yield of approximately one CTC per milliliter and typically low purity (Allard et al., 2004; Attard et al., 2009).”
de Bono, J. S., Scher, H. I., Montgomery, R. B., Parker, C., Miller, M. C., Tissing, H., Doyle, G. V., Terstappen, L. W. W. M., Pienta, K. J., & Raghavan, D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0872 · Cited by 2,182
Cited by
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Yu, M., Bardia, A., Wittner, B. S., Stott, S. L., Smas, M. E., Ting, D. T., Isakoff, S. J., Ciciliano, J. C., Wells, M. N., Shah, A. M., et al. (2013) · Science · doi:10.1126/science.1228522 · Cited by 2,476
Self-citationCirculating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
Aceto, N., Bardia, A., Miyamoto, D. T., Donaldson, M. C., Wittner, B. S., Spencer, J. A., Yu, M., Pely, A., Engstrom, A., Zhu, H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.013 · Cited by 2,441
Self-citationIntegrating liquid biopsies into the management of cancer
Siravegna, G., Marsoni, S., Siena, S., & Bardelli, A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.14 · Cited by 1,908
Epithelial–mesenchymal plasticity in carcinoma metastasis
Tsai, J. H., & Yang, J. (2013) · Genes & Development · doi:10.1101/gad.225334.113 · Cited by 1,136
Ozkumur, E., Shah, A. M., Ciciliano, J. C., Emmink, B. L., Miyamoto, D. T., Brachtel, E., Yu, M., Chen, P.-I., Morgan, B., Trautwein, J., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005616 · Cited by 1,086
Self-citationBaccelli, I., Schneeweiss, A., Riethdorf, S., Stenzinger, A., Schillert, A., Vogel, V., Klein, C., Saini, M., Bäuerle, T., Wallwiener, M., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2576 · Cited by 1,047
Wyatt Shields IV, C., Reyes, C. D., & López, G. P. (2015) · Lab on a Chip · doi:10.1039/c4lc01246a · Cited by 1,036
Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence
Chinen, A. B., Guan, C. M., Ferrer, J. R., Barnaby, S. N., Merkel, T. J., & Mirkin, C. A. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00321 · Cited by 1,032
Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
Yu, M., Bardia, A., Aceto, N., Bersani, F., Madden, M. W., Donaldson, M. C., Desai, R., Zhu, H., Comaills, V., Zheng, Z., et al. (2014) · Science · doi:10.1126/science.1253533 · Cited by 913
Self-citationMicrofluidic, marker-free isolation of circulating tumor cells from blood samples
Karabacak, N. M., Spuhler, P. S., Fachin, F., Lim, E. J., Pai, V., Ozkumur, E., Martel, J. M., Kojic, N., Smith, K., Chen, P.-I., et al. (2014) · Nature Protocols · doi:10.1038/nprot.2014.044 · Cited by 760
Self-citationLiquid biopsy in cancer: current status, challenges and future prospects
Ma, L., Guo, H., Zhao, Y., Liu, Z., Wang, C., Bu, J., Sun, T., & Wei, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02021-w · Cited by 712
A microfluidic device for label-free, physical capture of circulating tumor cell clusters
Sarioglu, A. F., Aceto, N., Kojic, N., Donaldson, M. C., Zeinali, M., Hamza, B., Engstrom, A., Zhu, H., Sundaresan, T. K., Miyamoto, D. T., et al. (2015) · Nature Methods · doi:10.1038/nmeth.3404 · Cited by 709
Self-citationBlood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
Haber, D. A., & Velculescu, V. E. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-1014 · Cited by 694
Self-citationNanoparticle-Based Immunochemical Biosensors and Assays: Recent Advances and Challenges
Farka, Z., Juřík, T., Kovář, D., Trnková, L., & Skládal, P. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00037 · Cited by 694
Molecular analysis of circulating tumour cells—biology and biomarkers
Krebs, M. G., Metcalf, R. L., Carter, L., Brady, G., Blackhall, F. H., & Dive, C. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.253 · Cited by 622
Advances and Applications of Single-Cell Sequencing Technologies
Wang, Y., & Navin, N. E. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.05.005 · Cited by 618
Slanted spiral microfluidics for the ultra-fast, label-free isolation of circulating tumor cells
Warkiani, M. E., Guan, G., Luan, K. B., Lee, W. C., Bhagat, A. A. S., Kant Chaudhuri, P., Tan, D. S.-W., Lim, W. T., Lee, S. C., Chen, P. C. Y., et al. (2014) · Lab Chip · doi:10.1039/c3lc50617g · Cited by 573
The biology of circulating tumor cells
Pantel, K., & Speicher, M. R. (2016) · Oncogene · doi:10.1038/onc.2015.192 · Cited by 539
Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer
Lohr, J. G., Adalsteinsson, V. A., Cibulskis, K., Choudhury, A. D., Rosenberg, M., Cruz-Gordillo, P., Francis, J. M., Zhang, C.-Z., Shalek, A. K., Satija, R., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2892 · Cited by 535
Ting, D. T., Wittner, B. S., Ligorio, M., Vincent Jordan, N., Shah, A. M., Miyamoto, D. T., Aceto, N., Bersani, F., Brannigan, B. W., Xega, K., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.029 · Cited by 527
Self-citationThe Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis
Zhang, L., Ridgway, L. D., Wetzel, M. D., Ngo, J., Yin, W., Kumar, D., Goodman, J. C., Groves, M. D., & Marchetti, D. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005109 · Cited by 521
Circulating tumor cell technologies
Ferreira, M. M., Ramani, V. C., & Jeffrey, S. S. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.01.007 · Cited by 511
Heitzer, E., Auer, M., Gasch, C., Pichler, M., Ulz, P., Hoffmann, E. M., Lax, S., Waldispuehl-Geigl, J., Mauermann, O., Lackner, C., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4140 · Cited by 497
Labelle, M., & Hynes, R. O. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0329 · Cited by 486
RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis
Yu, M., Ting, D. T., Stott, S. L., Wittner, B. S., Ozsolak, F., Paul, S., Ciciliano, J. C., Smas, M. E., Winokur, D., Gilman, A. J., et al. (2012) · Nature · doi:10.1038/nature11217 · Cited by 484
Self-citationClusters of circulating tumor cells traverse capillary-sized vessels
Au, S. H., Storey, B. D., Moore, J. C., Tang, Q., Chen, Y.-L., Javaid, S., Sarioglu, A. F., Sullivan, R., Madden, M. W., O’Keefe, R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524448113 · Cited by 478
Self-citationTechnologies for Single-Cell Isolation
Gross, A., Schoendube, J., Zimmermann, S., Steeb, M., Zengerle, R., & Koltay, P. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160816897 · Cited by 445
Extracellular vesicles as biomarkers and therapeutic targets for cancer
Urabe, F., Kosaka, N., Ito, K., Kimura, T., Egawa, S., & Ochiya, T. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00280.2019 · Cited by 397
Liu, X., Taftaf, R., Kawaguchi, M., Chang, Y.-F., Chen, W., Entenberg, D., Zhang, Y., Gerratana, L., Huang, S., Patel, D. B., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0065 · Cited by 390
Applications of Raman spectroscopy in cancer diagnosis
Auner, G. W., Koya, S. K., Huang, C., Broadbent, B., Trexler, M., Auner, Z., Elias, A., Mehne, K. C., & Brusatori, M. A. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9770-9 · Cited by 385
Cancer Invasion: Patterns and Mechanisms
Krakhmal, N. V., Zavyalova, M. V., Denisov, E. V., Vtorushin, S. V., & Perelmuter, V. M. (2015) · Acta Naturae · doi:10.32607/20758251-2015-7-2-17-28 · Cited by 374
Tracking cancer progression: from circulating tumor cells to metastasis
Castro-Giner, F., & Aceto, N. (2020) · Genome Medicine · doi:10.1186/s13073-020-00728-3 · Cited by 363
Technologies for circulating tumor cell separation from whole blood
Bankó, P., Lee, S. Y., Nagygyörgy, V., Zrínyi, M., Chae, C. H., Cho, D. H., & Telekes, A. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0735-4 · Cited by 358
Detecting Circulating Tumor Cells: Current Challenges and New Trends
Hong, B., & Zu, Y. (2013) · Theranostics · doi:10.7150/thno.5195 · Cited by 351
Considerations in the development of circulating tumor cell technology for clinical use
Parkinson, D. R., Dracopoli, N., Petty, B. G., Compton, C., Cristofanilli, M., Deisseroth, A., Hayes, D. F., Kapke, G., Kumar, P., Lee, J. S., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-138 · Cited by 323
Cancer genomics: one cell at a time
Navin, N. E. (2014) · Genome Biology · doi:10.1186/s13059-014-0452-9 · Cited by 318
Rare cell isolation and analysis in microfluidics
Chen, Y., Li, P., Huang, P.-H., Xie, Y., Mai, J. D., Wang, L., Nguyen, N.-T., & Huang, T. J. (2014) · Lab on a Chip · doi:10.1039/c3lc90136j · Cited by 307
Microfluidic approaches for cancer cell detection, characterization, and separation
Chen, J., Li, J., & Sun, Y. (2012) · Lab on a Chip · doi:10.1039/c2lc21273k · Cited by 301
Circulating tumor cell isolation for cancer diagnosis and prognosis
Deng, Z., Wu, S., Wang, Y., & Shi, D. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2022.104237 · Cited by 284
En Route to Metastasis: Circulating Tumor Cell Clusters and Epithelial-to-Mesenchymal Transition
Aceto, N., Toner, M., Maheswaran, S., & Haber, D. A. (2015) · Trends in Cancer · doi:10.1016/j.trecan.2015.07.006 · Cited by 276
Self-citationEngineering and physical sciences in oncology: challenges and opportunities
Mitchell, M. J., Jain, R. K., & Langer, R. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.83 · Cited by 273
Emerging role of tumor cell plasticity in modifying therapeutic response
Qin, S., Jiang, J., Lu, Y., Nice, E. C., Huang, C., Zhang, J., & He, W. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00313-5 · Cited by 268
Nucleic acid aptamers in cancer research, diagnosis and therapy
Ma, H., Liu, J., Ali, M. M., Mahmood, M. A. I., Labanieh, L., Lu, M., Iqbal, S. M., Zhang, Q., Zhao, W., & Wan, Y. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00357h · Cited by 265
Cancer Diagnosis: From Tumor to Liquid Biopsy and Beyond
Vaidyanathan, R., Soon, R. H., Zhang, P., Jiang, K., & Lim, C. T. (2018) · Lab on a Chip · doi:10.1039/c8lc00684a · Cited by 259
Sheng, W., Ogunwobi, O. O., Chen, T., Zhang, J., George, T. J., Liu, C., & Fan, Z. H. (2014) · Lab Chip · doi:10.1039/c3lc51017d · Cited by 257
Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
Sullivan, J. P., Nahed, B. V., Madden, M. W., Oliveira, S. M., Springer, S., Bhere, D., Chi, A. S., Wakimoto, H., Rothenberg, S. M., Sequist, L. V., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0471 · Cited by 255
Self-citationOrgan-on-chip models of cancer metastasis for future personalized medicine: From chip to the patient
Caballero, D., Kaushik, S., Correlo, V. M., Oliveira, J. M., Reis, R. L., & Kundu, S. C. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.10.005 · Cited by 221
Computational and Experimental Models of Cancer Cell Response to Fluid Shear Stress
Mitchell, M. J., & King, M. R. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00044 · Cited by 221
Carcinoma‐associated fibroblasts: Non‐neoplastic tumour‐promoting mesenchymal cells
Polanska, U. M., & Orimo, A. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24347 · Cited by 208
Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model
Zhang, Z., Shiratsuchi, H., Lin, J., Chen, G., Reddy, R. M., Azizi, E., Fouladdel, S., Chang, A. C., Lin, L., Jiang, H., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2592 · Cited by 207
Resistance to Fluid Shear Stress Is a Conserved Biophysical Property of Malignant Cells
Barnes, J. M., Nauseef, J. T., & Henry, M. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050973 · Cited by 203
Earhart, C. M., Hughes, C. E., Gaster, R. S., Ooi, C. C., Wilson, R. J., Zhou, L. Y., Humke, E. W., Xu, L., Wong, D. J., Willingham, S. B., et al. (2014) · Lab Chip · doi:10.1039/c3lc50580d · Cited by 165
Nanotechnology: emerging tools for biology and medicine
Wong, I. Y., Bhatia, S. N., & Toner, M. (2013) · Genes & Development · doi:10.1101/gad.226837.113 · Cited by 132
Self-citationThe Fluid Mechanics of Cancer and Its Therapy
Koumoutsakos, P., Pivkin, I., & Milde, F. (2013) · Annual Review of Fluid Mechanics · doi:10.1146/annurev-fluid-120710-101102 · Cited by 129
Research progress of CTC, ctDNA, and EVs in cancer liquid biopsy
Wang, X., Wang, L., Lin, H., Zhu, Y., Huang, D., Lai, M., Xi, X., Huang, J., Zhang, W., & Zhong, T. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1303335 · Cited by 112
Hyun, K.-A., Lee, T. Y., & Jung, H.-I. (2013) · Analytical Chemistry · doi:10.1021/ac3037766 · Cited by 102
Plouffe, B. D., Mahalanabis, M., Lewis, L. H., Klapperich, C. M., & Murthy, S. K. (2012) · Analytical Chemistry · doi:10.1021/ac2022844 · Cited by 96
An integrated microfluidic chip for one-step isolation of circulating tumor cells
Lee, T. Y., Hyun, K.-A., Kim, S.-I., & Jung, H.-I. (2017) · Sensors and Actuators B: Chemical · doi:10.1016/j.snb.2016.05.163 · Cited by 94
Microfluidic platform for negative enrichment of circulating tumor cells
Sajay, B. N. G., Chang, C.-P., Ahmad, H., Khuntontong, P., Wong, C. C., Wang, Z., Puiu, P. D., Soo, R., & Rahman, A. R. A. (2014) · Biomedical Microdevices · doi:10.1007/s10544-014-9856-2 · Cited by 56
Analyzing Circulating Tumor Cells One at a Time
Ortiz, V., & Yu, M. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.05.004 · Cited by 48
Self-citationRayavarapu, R. R., Heiden, B., Pagani, N., Shaw, M. M., Shuff, S., Zhang, S., & Schafer, Z. T. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.612754 · Cited by 42
Liao, C.-J., Hsieh, C.-H., Wang, H.-M., Chou, W.-P., Chiu, T.-K., Chang, J.-H., Chao, A.-C., & Wu, M.-H. (2017) · RSC Advances · doi:10.1039/c7ra03663a · Cited by 20
An integrated microfluidic platform for negative selection and enrichment of cancer cells 6
Luo, W.-Y., Tsai, S.-C., Hsieh, K., & Lee, G.-B. (2015) · Journal of Micromechanics and Microengineering · doi:10.1088/0960-1317/25/8/084007 · Cited by 18
Metadata
- Authors
- Yu, M., Stott, S., Toner, M., Maheswaran, S., & Haber, D. A.
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2011-02-07
- Volume
- 192
- Issue
- 3
- Pages
- 373-382
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W2138665978
- Cited by
- 1,089
- References
- 93
- FWCI
- 29.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.